Northern Therapeutics   Report issue

For profit Phase 1 Phase 2
Founded: Montreal Canada (2000)

Organization Overview

First Clinical Trial
2006
NCT00469027
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Northern Therapeutics